TSC2 and cardiac rhabdomyoma: Furthermore, TSC2 pathogenic variant carriers are at greater risk for renal malignancies, cardiac rhabdomyomas, intellectual disability, infantile epileptic spasms, and drug-resistant epilepsy [81,87,88,89].